157 related articles for article (PubMed ID: 8438617)
1. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model.
Mallett CP; VanDeVerg L; Collins HH; Hale TL
Vaccine; 1993; 11(2):190-6. PubMed ID: 8438617
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers.
Li A; Kärnell A; Huan PT; Cam PD; Minh NB; Trâm LN; Quy NP; Trach DD; Karlsson K; Lindberg G
Vaccine; 1993; 11(2):180-9. PubMed ID: 8438616
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
[TBL] [Abstract][Full Text] [Related]
5. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.
van de Verg LL; Mallett CP; Collins HH; Larsen T; Hammack C; Hale TL
Infect Immun; 1995 May; 63(5):1947-54. PubMed ID: 7729907
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
Orr N; Robin G; Cohen D; Arnon R; Lowell GH
Infect Immun; 1993 Jun; 61(6):2390-5. PubMed ID: 8500877
[TBL] [Abstract][Full Text] [Related]
7. Immunoprophylaxis against bacillary dysentery by dysentery live vaccine Vadizen (Shigella flexneri T32-Istrati) in children collectivities in SV County.
Bogus L; Ianopol L; Dascălu C; Bende B; Iliescu C; Carliuc V; Meitert T; Pencu E; Ciudin L; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):291-8. PubMed ID: 6400302
[No Abstract] [Full Text] [Related]
8. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).
Meitert T; Pencu E; Ciudin L; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299
[No Abstract] [Full Text] [Related]
9. Results of dysentery vaccinations by live vaccine Vadizen (Sh. flexneri 2a T32-Istrati) in children collectivities in GL.
Brebenel G; Barabas E; Delcea D; Meitert T; Pencu E; Ciudin L
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):299-304. PubMed ID: 6400303
[No Abstract] [Full Text] [Related]
10. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
[No Abstract] [Full Text] [Related]
11. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
[No Abstract] [Full Text] [Related]
12. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.
Phalipon A; Kaufmann M; Michetti P; Cavaillon JM; Huerre M; Sansonetti P; Kraehenbuhl JP
J Exp Med; 1995 Sep; 182(3):769-78. PubMed ID: 7544397
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF
Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.
Van De Verg LL; Bendiuk NO; Kotloff K; Marsh MM; Ruckert JL; Puryear JL; Taylor DN; Hartman AB
Vaccine; 1996 Aug; 14(11):1062-8. PubMed ID: 8879103
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylactic effect of dysentery vaccination by live dysentery vaccine Vadizen (Sh. flexneri T32-Istrati) in children and adult collectivities in BT County.
Cîmpeanu S; Harasim T; Popovici S; Popa T; Meitert T; Pencu E; Ciudin L; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):305-12. PubMed ID: 6400304
[No Abstract] [Full Text] [Related]
17. Antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in PH County.
Cuteanu I; Malamen G; Vlad A; Meitert T; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):313-21. PubMed ID: 6400305
[No Abstract] [Full Text] [Related]
18. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
[TBL] [Abstract][Full Text] [Related]
20. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
